Lab News
AMP roundup: Vendors showcase same-day NGS, faster prep, DNA/RNA combos
November 7, 2019 -- BALTIMORE - Bruce Carlson, publisher of Kalorama Information, is on the ground at the Baltimore Convention Center for this week's Association for Molecular Pathology (AMP) meeting, reporting on product introductions.  Discuss
AMP lineup shows changing of the guard in molecular tech
November 6, 2019 -- Bruce Carlson, publisher of Kalorama Information, shares his thoughts on the many vendor workshops slated for the upcoming Association for Molecular Pathology (AMP) annual meeting in Baltimore.  Discuss
FDA flags persistent problems with biotin interference
November 5, 2019 -- The U.S. Food and Drug Administration (FDA) on November 5 issued a warning regarding lab tests that have not yet been addressed for biotin interference. The communiqué instructs lab personnel to communicate more with patients and health providers to help avoid false reporting.  Discuss
ACP advises biennial -- not annual -- stool tests for colon cancer
November 5, 2019 -- In a debatable move, the American College of Physicians (ACP) advised biennial -- rather than annual -- testing of stool for signs of colorectal cancer in average-risk individuals in a clinical guideline published November 5 in the Annals of Internal Medicine. Furthermore, stool DNA testing did not make the cut.  Discuss
CA-125 blood test better than expected in ovarian cancer
November 5, 2019 -- The performance of the cancer antigen 125 (CA-125) blood test for detecting ovarian cancer surpassed expectations in a study of more than 50,000 symptomatic women seen in primary care, researchers reported on November 5 at the U.K. National Cancer Research Institute meeting in Glasgow.  Discuss
Cancer patients starved for information on genomic test costs
November 4, 2019 -- Oncologists have a lot of room for improvement when it comes to discussing the costs associated with genomic testing with their patients, according to a survey published on November 1 in the Journal of the National Cancer Institute.  Discuss
Hahn nominated to lead FDA as commissioner
November 4, 2019 -- Radiation oncologist Dr. Stephen Hahn has been nominated as commissioner of the U.S. Food and Drug Administration (FDA). The nomination is drawing plaudits from the American Society for Radiation Oncology and other cancer organizations.  Discuss
Hormones in blood signal risk for prostate cancer
November 1, 2019 -- A higher level of insulin-like growth factor 1 in healthy men was associated with subsequent diagnosis and death from prostate cancer in a new prospective study of more than 200,000 UK Biobank participants.  Discuss
Disability agency urges crackdown on prenatal genetic testing
October 31, 2019 -- The U.S. National Council on Disability is calling for greater regulation of genetic testing -- with a particular focus on noninvasive prenatal testing (NIPT) -- in a new report. The agency analyzed the game-changing effects that NIPT has had on genetic testing and analysis.  Discuss
CMS plans broader coverage for NGS in breast, ovarian cancer
October 30, 2019 -- The U.S. Centers for Medicare and Medicaid Services (CMS) has proposed broad national coverage for next-generation sequencing (NGS) in Medicare patients to check for germline mutations under certain testing conditions.  Discuss
Oncologic Pathology: A Review and Update of Diagnostic Problems
November 21-23
Miami, Florida United States
American Society of Hematology (ASH) Annual Meeting & Exposition
December 7-10
Orlando, Florida United States
Semiannual IVD Clinical and Regulatory Affairs Conference
December 12-13
San Diego, California United States
Precision Medicine World Conference (PMWC) 2020
January 21-24, 2020
Santa Clara, California United States
Society for Laboratory Automation and Screening (SLAS) 2020
January 25-29, 2020
San Diego, California United States
LabPulse on LinkedIn
LabPulse on Facebook
LabPulse on Twitter
Latest Tweets